Methotrexate (MTX) failed to control giant cell arteritis (GCA)
Egile Nagusiak: | Hoffman, G, Cid, M, Hellmann, D, Merkel, P, Guillevin, L, Dickler, H, Calabrese, L, Locker, G, Easley, K, Bedocs, N, Fortin, P, Schousboe, J, Sherrer, Y, Swanson, H, Walsh, B, Gross, W, Luqmani, R, Hunder, G, Sneller, M, Flynn, J, Stone, J, Ludivico, C, Kalunian, K |
---|---|
Formatua: | Journal article |
Argitaratua: |
2001
|
Antzeko izenburuak
-
A multicenter placebo-controlled study of methotrexate (MTX) in giant cell arteritis (GCA).
nork: Hoffman, G, et al.
Argitaratua: (2000) -
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.
nork: Hoffman, G, et al.
Argitaratua: (2002) -
How to get the most from methotrexate (MTX) treatment for your rheumatoid arthritis patient?—MTX in the treat-to-target strategy
nork: Taylor, P, et al.
Argitaratua: (2019) -
THU0296 The role of ultrasound in the management of giant cell arteritis (GCA) in routine clinical practice
nork: Monti, S, et al.
Argitaratua: (2017) -
The role of a standardised ultrasound protocol in the management of giant cell arteritis (GCA) in routine clinical practice
nork: Monti, S, et al.
Argitaratua: (2017)